ADA

Dapagliflozin Effective in T2D with HFrEF Regardless of Type of Background T2D Therapy
June 19, 2020

VIDEO: Kieran Docherty, MBChB, discusses results of the DAPA-HF analysis on the impact of background T2D therapy on clinical outcomes in patients with T2D and HFrEF.

Glycemic Control in US Youth, Young Adults Disappointing
June 17, 2020

ADA 2020. Average A1c for a recent young cohort with type 2 diabetes was 8.5%, according to research presented at the ADA Virtual Scientific Sessions.

Physician CKD Awareness in T2D Patients Linked to CKD Severity
June 17, 2020

Physicians’ CKD awareness in T2D is linked with CKD severity, suggests a new study presented this week at the American Diabetes Association’s 80th Virtual Scientific Sessions.